Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical and Translational Radiation Oncology|April 17, 2018
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivoSteffi Liebscher, Lydia Koi, Steffen Löck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2017
EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft modelsLydia Koi, Steffen Löck, Annett Linge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour modelsChiara Valentini, Nadja Ebert, Lydia Koi, et al.
Radiation Oncology (London, England)|September 20, 2014
BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenograftsLinda Helbig, Lydia Koi, Kerstin Brüchner, et al.
International Journal of Cancer|July 31, 2019
Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivoKristin Gurtner, Zofia Kryzmien, Lydia Koi, et al.
Oncotarget|October 14, 2015
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinomaIna Kurth, Linda Hein, Katrin Mäbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 21, 2014
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potentialLydia Koi, Ralf Bergmann, Kerstin Brüchner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probabilityAla Yaromina, Lydia Koi, Lesley Schuitmaker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiationLinda Helbig, Lydia Koi, Kerstin Brüchner, et al.
Cancers|April 30, 2021
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell CarcinomasLina Lüttich, María José Besso, Stephan Heiden, et al.
Pageof 2